|
|
SciBase Letter from the CEO no 5: Launch of updated Strategy |
|
|
SciBase announces outcome of the preferential rights issue |
|
|
SciBase closes first DermoScan integration sale in Germany |
|
|
Publication of prospectus in connection with SciBase's preferential rights issue |
|
|
Bulletin from extra general meeting of SciBase Holding AB (publ) on 15 November 2017 |
|
|
Goldenberg Dermatology first in the US to offer SciBase's Nevisense screening for early detection of melanoma |
|
|
Interim Report |
|
|
SciBase receives first commercial order in the US from private clinic in New York |
|
|
SciBase receives order of up to 1 million SEK within a new customer segment in Italy |
|
|
SciBase letter from the CEO number 4: Updated strategy and securing our long-term capital needs |
